Mufson Howe Hunter & Company is pleased to announce that PDS Life Sciences, a leading provider of software and outsourced services to the global life sciences market, has been acquired by Instem plc.
Headquartered in Switzerland, with offices in the United States and Japan, PDS has been a direct competitor of Instem, providing software and outsourced services for non-clinical study management and regulatory submissions using SEND (the Standard for the Exchange of Non-clinical Data). Seven of the world’s top ten pharmaceutical companies rely on PDS, as do leading Contract Research Organizations, chemical companies, universities, and regulatory agencies.
“This was a natural next step in our quest to help clients do more and go further than ever before. MHH provided us with excellent advice throughout the process and was instrumental in helping us achieve an outstanding outcome for all stakeholders,” said Vicente Nogués, CEO at PDS.
MHH acted as PDS’s exclusive financial advisor for the transaction. This engagement underscores MHH’s commitment to partnering with leading vertical software and technology-enabled service companies and highlights the firm’s deep domain expertise and established relationships in the sector.
About PDS
For more than 40 years, we’ve developed software for scientists by scientists — a hallmark, unrivaled in our industry. For that reason, seven of the world’s top 10 pharma companies rely on PDS, as do leading CROs, chemical companies, universities, and regulatory agencies. Innovation, GLP Compliance, and intuitive SaaS solutions are the cornerstones of our success. Our SaaS platforms for SEND and LIMS are designed from the ground up to meet CDISC, ISO, and GLP standards.
About Mufson Howe Hunter & Company
MHH, an investment banking firm established in 2004, focuses on merger and acquisition transactions and the placement of growth capital for privately-held, middle market companies. MHH’s Technology & Services practice serves growth-oriented, rapidly scalable businesses that leverage proprietary and enabling technologies to address the evolving needs of modern enterprise customers. We apply deep industry expertise and broad transaction experience to provide thoughtful, tailored advice and solutions for our clients. Our clients turn to us for outstanding M&A advisory and capital-raising execution.
